tiprankstipranks
Trending News
More News >
Svolder AB Class B (SE:SVOL.B)
:SVOL.B

Svolder AB Class B (SVOL.B) AI Stock Analysis

Compare
0 Followers

Top Page

SE

Svolder AB Class B

(Frankfurt:SVOL.B)

Rating:64Neutral
Price Target:
Svolder AB Class B's overall stock score is driven by strong financial stability due to a robust balance sheet and recovering profitability. Technical analysis suggests neutral to slightly bearish trends with potential overbought conditions. The valuation supports a reasonable investment case with a balanced P/E ratio and attractive dividend yield. The absence of additional corporate or earnings call events maintains focus on these primary factors.

Svolder AB Class B (SVOL.B) vs. iShares MSCI Sweden ETF (EWD)

Svolder AB Class B Business Overview & Revenue Model

Company DescriptionSvolder AB is a Sweden-based investment company that primarily operates in the financial sector. The company specializes in investing in small and medium-sized publicly traded companies, predominantly in Sweden, aiming to generate long-term capital appreciation. It operates as a closed-end investment firm and is listed on the Stockholm Stock Exchange, providing investors with opportunities to participate in a diversified portfolio of equities.
How the Company Makes MoneySvolder AB makes money primarily through capital gains and dividends from its investment portfolio. The company's revenue model is based on investing in carefully selected small and medium-sized companies, holding these investments over time to benefit from their potential growth, and generating returns as these companies increase in value. Additionally, Svolder earns income from dividends distributed by the companies it invests in. The firm's performance is also influenced by its ability to effectively manage its portfolio, including buying and selling equities based on market conditions and company fundamentals. Significant partnerships with brokerage firms and financial institutions may also play a role in facilitating its investment activities and market transactions.

Svolder AB Class B Financial Statement Overview

Summary
Overall, Svolder AB Class B demonstrates a strong balance sheet with zero debt and high equity. The income statement shows recovering profitability in the TTM after years of negative revenue and profit. Cash flows are positive and improving, though room for growth remains. The company is on a path to recovery with a stable financial foundation, albeit with previous volatility in earnings.
Income Statement
42
Neutral
The income statement shows a volatile revenue trajectory with negative revenue in recent years, but a positive turnaround in TTM (Trailing-Twelve-Months). Gross profit margin is negative due to a substantial gross loss. However, there is an improvement in EBIT and net profit margins due to higher EBIT and net income in the TTM, indicating some operational efficiency gains.
Balance Sheet
85
Very Positive
The balance sheet is strong with zero debt, resulting in a debt-to-equity ratio of zero, which suggests no leverage risk. The equity ratio is high, indicating a strong capital base. The return on equity is variable due to fluctuating net income, but the overall financial stability is maintained through high stockholders' equity.
Cash Flow
77
Positive
The cash flow statement highlights positive free cash flow and operating cash flow, with a significant improvement in operating cash flow in TTM. The free cash flow to net income ratio is strong, indicating effective cash conversion. However, the free cash flow growth rate is modest, reflecting some challenges in capital allocation.
BreakdownTTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income Statement
Total Revenue450.56M894.46M-489.00M-1.15B3.51B704.23M
Gross Profit450.56M894.46M-493.48M-1.15B3.51B710.40M
EBITDA895.40M149.78M-530.04M-1.19B3.49B690.16M
Net Income432.00M876.20M-525.50M-1.19B3.49B690.10M
Balance Sheet
Total Assets5.93B6.03B5.27B5.88B7.13B3.70B
Cash, Cash Equivalents and Short-Term Investments642.00M323.90M190.20M734.10M429.90M245.60M
Total Debt0.000.000.000.0020.10M2.40M
Total Liabilities34.90M6.40M21.50M15.40M10.90M14.00M
Stockholders Equity5.90B6.02B5.25B5.87B7.12B3.69B
Cash Flow
Free Cash Flow113.20M86.40M77.50M113.10M73.40M-15.40M
Operating Cash Flow113.40M86.50M77.60M113.20M73.40M-15.40M
Investing Cash Flow406.70M149.50M-529.30M255.00M167.20M95.90M
Financing Cash Flow-174.10M-102.40M-92.20M-64.00M-56.30M-55.00M

Svolder AB Class B Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price55.50
Price Trends
50DMA
57.13
Negative
100DMA
56.24
Negative
200DMA
55.67
Positive
Market Momentum
MACD
-0.70
Negative
RSI
47.23
Neutral
STOCH
67.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SVOL.B, the sentiment is Neutral. The current price of 55.5 is below the 20-day moving average (MA) of 56.16, below the 50-day MA of 57.13, and below the 200-day MA of 55.67, indicating a neutral trend. The MACD of -0.70 indicates Negative momentum. The RSI at 47.23 is Neutral, neither overbought nor oversold. The STOCH value of 67.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:SVOL.B.

Svolder AB Class B Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
kr13.06B27.114.06%3.42%-5.70%-62.59%
65
Neutral
kr119.24B24.787.49%4.22%13.90%-82.08%
64
Neutral
kr5.73B13.31-3.12%3.09%
63
Neutral
kr3.82B96.907.13%0.30%2.42%20.90%
62
Neutral
kr7.05B35.4916.42%10.18%-1.08%
57
Neutral
kr4.24B17.495.76%37.32%-39.07%
56
Neutral
kr21.35B184.080.27%0.96%13.61%-97.82%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:SVOL.B
Svolder AB Class B
55.30
-5.79
-9.47%
SE:RATO.B
Ratos AB
38.90
3.63
10.30%
SE:BURE
Bure Equity AB
289.40
-57.75
-16.63%
SE:IDUN.B
Idun Industrier AB Class B
340.00
98.66
40.88%
SE:LINC
Linc AB
76.30
-12.20
-13.79%
SE:MCAP
MedCap AB
482.00
-37.00
-7.13%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 24, 2025